Anti-CTLA-4 therapy CTLA-4 blockade has limited effectiveness as a single agent, but may prove to be useful as an adjunct to other therapies in the treatment of metastatic melanoma. Tested doses ...

Of 391 projects KDDF has supported since 2021, 44 have focused on immunological therapies (Fig. 1). KDDF focuses its support on projects involving globally competitive novel targets and next ...